Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Kher, U"'
Autor:
Van Cutsem, E., Valderrama, A., Bang, Y.-J., Fuchs, C.S., Shitara, K., Janjigian, Y.Y., Qin, S., Larson, T.G., Shankaran, V., Stein, S., Norquist, J.M., Kher, U., Shah, S., Alsina, M.
Publikováno v:
In ESMO Open August 2021 6(4)
Autor:
Van Cutsem, E., Valderrama, A., Bang, Yung-Jue, Fuchs, C. S., Shitara, Kohei, Janjigian, Y. Y., Qin, S., Larson, T. G., Shankaran, V., Stein, S., Norquist, J. M., Kher, U., Shah, S., Alsina, Maria, Universitat Autònoma de Barcelona
Publikováno v:
ESMO Open
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Background In the randomised phase III KEYNOTE-062 study, pembrolizumab was non-inferior to chemotherapy for overall survival in patients with programmed death-ligand 1 (PD-L1)-positive [combined positive score (CPS) ≥1] advanced gastric/gastroesop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574353a1a2b648f0617caf724448b5cb
https://lirias.kuleuven.be/handle/123456789/680659
https://lirias.kuleuven.be/handle/123456789/680659
Autor:
Kher, U., Tunkiwala, A.
Publikováno v:
Clinical Dentistry Reviewed; 6/15/2020, Vol. 4 Issue 1, p1-12, 12p
Autor:
Park A, Buechner MM, Locke L, Walsh B, Adams K, Lemonick MD, Masters C, Gumbel P, Sayre C, Sharick C, Kher U, Smith A, Bjerklie D, Graff J, Kirchner S, Robinson S
Publikováno v:
TIME Magazine; 4/9/2007, Vol. 169 Issue 15, p69-82, 11p
Publikováno v:
TIME Magazine; 12/11/2006, Vol. 168 Issue 24, p64-68, 4p
Publikováno v:
TIME Magazine; 5/29/2006, Vol. 167 Issue 22, p44-47, 4p
Autor:
Chung, H.C., Bang, Y.-J., Tabernero, J., Van Cutsem, E., Fuchs, C.S., Wyrwicz, L., Lee, K.-W., Kudaba, I., Garrido, M., Castro, H., Mansoor, W., Braghiroli, M.I., Goekkurt, E., Chao, J., Wainberg, Z.A., Kher, U., Shah, S., Shitara, K.
Publikováno v:
In Annals of Oncology November 2019 30 Supplement 9:ix43-ix44
Autor:
Van Cutsem, E. 1, Valderrama, A. 2, Bang, Y.-J. 3, Fuchs, C. 4, Shitara, K. 5, Janjigian, Y.Y. 6, Qin, S. 7, Larson, T. 8, Shankaran, V. 9, Stein, S. 4, Norquist, J.M. 2, Kher, U. 10, Shah, S. 10, Alsina, M. 11
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v879-v879
Autor:
Shitara, K. 1, Van Cutsem, E. 2, Bang, Y.-J. 3, Fuchs, C.S. 4, Wyrwicz, L. 5, Lee, K.W. 6, Kudaba, I. 7, Garrido, M. 8, Cheol Chung, H. 9, Castro, H.R. 10, Mansoor, W. 11, Braghiroli, M I F M 12, Goekkurt, E. 13, Chao, J. 14, Wainberg, Z.A. 15, Kher, U. 16, Shah, S. 16, Kang, S.P. 16, Tabernero, J. 17
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v878-v879
Autor:
Tabernero, J., Van Cutsem, E., Bang, Y., Fuchs, C., Wyrwicz, L., Lee, K., Kudaba, I., Garrido, M., Chung, H., Castro Salguero, H., Mansoor, W., Braghiroli, M., Goekkurt, E., Chao, J., Wainberg, Z., Kher, U., Shah, S., Kang, S., Shitara, K.
Publikováno v:
In Annals of Oncology July 2019 30 Supplement 4:iv152-iv153